Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5322 ARTÍCULOS , VIENDO DEL 1366 AL 1380

Safety review of current pharmacotherapies for levodopa-treated patients with Parkinson's disease

Richmond AM, Lyons KE, Pahwa R.

Expert Opin Drug Saf. 2023 Jul-Dec;22(7):563-579. doi: 10.1080/14740338.2023.2227096. Epub 2023 Jul 4.

[Relationships between microbiome and neurodegeneration]

Bang C, Heinzel S.

Nervenarzt. 2023 Oct;94(10):885-891. doi: 10.1007/s00115-023-01537-w. Epub 2023 Sep 6.

Positive and negative cell therapy in randomized control trials for central nervous system diseases

Chen D, Huang H, Saberi H, Sharma HS.

Int Rev Neurobiol. 2023;171:241-254. doi: 10.1016/bs.irn.2023.05.017. Epub 2023 Sep 15.

From Recognition to Remedy: The Significance of Biomarkers in Neurodegenerative Disease Pathology

Toader C, Dobrin N, Brehar FM, Popa C, Covache-Busuioc RA, Glavan LA, Costin HP, Bratu BG, Corlatescu AD, Popa AA, Ciurea AV.

Int J Mol Sci. 2023 Nov 9;24(22):16119. doi: 10.3390/ijms242216119.

Early Onset Parkinson Syndrome, Type A Aortic Aneurysm and Noncompaction Associated With the Novel Variant c.2225C>T in MYH11: A Case Report

Finsterer J, Mehri S.

Cureus. 2023 Oct 10;15(10):e46793. doi: 10.7759/cureus.46793. eCollection 2023 Oct.

When Patient Expectations Are Not Met: A Case Report

Sadowsky A, Porat Y, Faruki AA, Vitter JS.

A A Pract. 2023 Jun 19;17(6):e01686. doi: 10.1213/XAA.0000000000001686. eCollection 2023 Jun 1.

Pimavanserin Use in Lewy Body Dementia: A Case Report Demonstrating the Medication's Efficacy

Baker M, Song W, Fusick A.

Cureus. 2023 Oct 2;15(10):e46356. doi: 10.7759/cureus.46356. eCollection 2023 Oct.

Adaptive Deep Brain Stimulation: From Experimental Evidence Toward Practical Implementation

Neumann WJ, Gilron R, Little S, Tinkhauser G.

Mov Disord. 2023 Jun;38(6):937-948. doi: 10.1002/mds.29415. Epub 2023 May 6.

Scales for Antipsychotic-Associated Movement Disorders: Systematic Review, Critique, and Recommendations

Martino D, Karnik V, Bhidayasiri R, Hall DA, Hauser RA, Macerollo A, Pringsheim TM, Truong D, Factor SA, Skorvanek M, Schrag A; Members of the IPMDS Rating Scales Review Committee.

Mov Disord. 2023 Jun;38(6):1008-1026. doi: 10.1002/mds.29392. Epub 2023 Apr 20.

Lithium-induced parkinsonism associated with vocal cord paralysis: an atypical presentation

Raia A, Montalbano C, Caruso V, Pacciardi B, Pini S.

Arch Clin Cases. 2023 Jun 23;10(2):107-109. doi: 10.22551/2023.39.1002.10252. eCollection 2023.

Natural Walking Intensity in Persons With Parkinson Disease

Girnis JL, Cavanaugh JT, Baker TC, Duncan RP, Fulford D, LaValley MP, Lawrence M, Nordahl T, Porciuncula F, Rawson KS, Saint-Hilaire M, Thomas CA, Zajac JA, Earhart GM, Ellis TD.

J Neurol Phys Ther. 2023 Jul 1;47(3):146-154. doi: 10.1097/NPT.0000000000000440. Epub 2023 Apr 4.

LRRK2 and Parkinson's disease: from genetics to targeted therapy

Sosero YL, Gan-Or Z.

Ann Clin Transl Neurol. 2023 Jun;10(6):850-864. doi: 10.1002/acn3.51776. Epub 2023 Apr 6.

Mixed pathology as a rule, not exception: Time to reconsider disease nosology

Chu Y, Hirst WD, Kordower JH.

Handb Clin Neurol. 2023;192:57-71. doi: 10.1016/B978-0-323-85538-9.00012-2.

Parkinsonism Sac domain mutation in Synaptojanin-1 affects ciliary properties in iPSC-derived dopaminergic neurons

Rafiq NM, Fujise K, Rosenfeld MS, Xu P, Wu Y, De Camilli P.

bioRxiv [Preprint]. 2023 Oct 13:2023.10.12.562142. doi: 10.1101/2023.10.12.562142.

Serotonergic Medication Error: A Case Report of Serotonin Syndrome

Nguyen ATN, Fisher RG, Valentine MJ, Kayastha A, Pham HM, Phu AT, Meimon SA, Newsome-Cuby TR, Parry CA, Kirila CE.

Cureus. 2023 Nov 2;15(11):e48161. doi: 10.7759/cureus.48161. eCollection 2023 Nov.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias